Eastern Virginia Medical School

evms.edu

Total trials

56

Active

7

Phase 3

5

Total enrollment

6,473

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 7 of 7 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
5% Dextrose1
Lactate Ringer1
Use of insulin glargine once daily1
Use of insulin glargine twice daily1
Oxytocin plus Foley Catheter1
Oxytocin1
THC-free CBD Oil1

Next readouts

  • 2024-03
  • 2026-03
  • 2026-07-30
  • 2027-12-01

Top conditions

  • Sleep Apnea, Obstructive3
  • Adherence, Medication3
  • Pregestational Diabetes2
  • Safety Issues2
  • Diabetic Peripheral Neuropathy1
  • Nerve Pain1
  • Papillomavirus Vaccines1
  • Diabetic; Neuropathic, Polyneuropathy (Manifestation)1

Frequently asked questions about Eastern Virginia Medical School

How many clinical trials does Eastern Virginia Medical School have on ClinicalTrials.gov?
Eastern Virginia Medical School is listed as the lead sponsor on 56 clinical trials in ClinicalTrials.gov, 7 of which are currently active (recruiting, enrolling, or ongoing).
How many of Eastern Virginia Medical School's trials are in Phase 3?
5 of Eastern Virginia Medical School's trials are in Phase 3, spread across 7 active drug programs.
What therapeutic areas does Eastern Virginia Medical School focus on?
Eastern Virginia Medical School's most-studied conditions on ClinicalTrials.gov are Sleep Apnea, Obstructive, Adherence, Medication, Pregestational Diabetes, Safety Issues, Diabetic Peripheral Neuropathy.
When are Eastern Virginia Medical School's next clinical trial readouts?
Eastern Virginia Medical School has 4 upcoming primary-completion readouts tracked here; the soonest is “Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease”, expected around 2024-03.